32.65
price up icon0.12%   0.04
after-market Dopo l'orario di chiusura: 32.65
loading
Precedente Chiudi:
$32.61
Aprire:
$32.42
Volume 24 ore:
202.39K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.65B
Reddito:
$357.71M
Utile/perdita netta:
$-20.10M
Rapporto P/E:
-82.47
EPS:
-0.3959
Flusso di cassa netto:
$28.67M
1 W Prestazione:
+0.49%
1M Prestazione:
-7.17%
6M Prestazione:
+10.38%
1 anno Prestazione:
-9.68%
Intervallo 1D:
Value
$32.42
$33.08
Intervallo di 1 settimana:
Value
$32.07
$33.62
Portata 52W:
Value
$23.15
$39.33

Immunocore Holdings Plc Adr Stock (IMCR) Company Profile

Name
Nome
Immunocore Holdings Plc Adr
Name
Telefono
01235 5430281
Name
Indirizzo
90 PARK DRIVE, OXFORDSHIRE
Name
Dipendente
493
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
IMCR's Discussions on Twitter

Confronta IMCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IMCR
Immunocore Holdings Plc Adr
32.65 1.64B 357.71M -20.10M 28.67M -0.3959
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-27 Iniziato Deutsche Bank Buy
2024-12-13 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-11-11 Downgrade Mizuho Outperform → Neutral
2024-10-24 Iniziato UBS Sell
2024-10-07 Downgrade Guggenheim Buy → Neutral
2024-04-29 Iniziato Leerink Partners Outperform
2023-11-20 Ripresa JP Morgan Overweight
2023-11-02 Iniziato Cantor Fitzgerald Overweight
2023-10-31 Iniziato Robert W. Baird Outperform
2023-09-13 Aggiornamento JP Morgan Neutral → Overweight
2023-09-13 Iniziato Needham Buy
2023-08-16 Iniziato CapitalOne Overweight
2023-07-17 Iniziato Canaccord Genuity Hold
2023-03-31 Iniziato Mizuho Buy
2023-03-30 Iniziato Guggenheim Buy
2023-03-24 Iniziato Bryan Garnier Buy
2022-12-16 Aggiornamento Goldman Neutral → Buy
2022-11-30 Iniziato Barclays Overweight
2022-09-09 Iniziato Morgan Stanley Overweight
2022-09-08 Iniziato Ladenburg Thalmann Buy
2022-08-08 Iniziato Cowen Outperform
2022-08-02 Iniziato BTIG Research Buy
2022-02-08 Iniziato H.C. Wainwright Buy
2021-10-20 Iniziato Oppenheimer Outperform
2021-03-02 Iniziato Goldman Neutral
2021-03-02 Iniziato JP Morgan Overweight
2021-03-02 Iniziato Jefferies Buy
Mostra tutto

Immunocore Holdings Plc Adr Borsa (IMCR) Ultime notizie

pulisher
Aug 26, 2025

Immunocore (NASDAQ:IMCR) Coverage Initiated by Analysts at Jefferies Financial Group - Defense World

Aug 26, 2025
pulisher
Aug 21, 2025

Earnings call transcript: Immunocore Q2 2025 beats revenue forecast - Investing.com

Aug 21, 2025
pulisher
Aug 21, 2025

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives $58.00 Consensus Price Target from Brokerages - Defense World

Aug 21, 2025
pulisher
Aug 15, 2025

Q3 Earnings Estimate for Immunocore Issued By HC Wainwright - Defense World

Aug 15, 2025
pulisher
Aug 14, 2025

FY2027 EPS Estimates for Immunocore Boosted by HC Wainwright - Defense World

Aug 14, 2025
pulisher
Aug 14, 2025

Immunocore’s SWOT analysis: stock outlook amid clinical milestones, market challenges - Investing.com

Aug 14, 2025
pulisher
Aug 08, 2025

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi - sharewise.com

Aug 08, 2025
pulisher
Aug 08, 2025

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues - sharewise.com

Aug 08, 2025
pulisher
Aug 07, 2025

Immunocore (IMCR) Q2 Revenue Jumps 30% - The Motley Fool

Aug 07, 2025
pulisher
Aug 07, 2025

Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Immunocore Holdings earnings missed by $0.02, revenue topped estimates - Investing.com South Africa

Aug 07, 2025
pulisher
Aug 06, 2025

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View - Yahoo Finance

Aug 06, 2025
pulisher
Aug 05, 2025

TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line - sharewise.com

Aug 05, 2025
pulisher
Aug 01, 2025

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down - Yahoo Finance

Aug 01, 2025
pulisher
Jul 31, 2025

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Barchart.com

Jul 31, 2025
pulisher
Jul 31, 2025

Immunocore to Report Q2 2025 Financial Results on August 7, 2025 - AInvest

Jul 31, 2025
pulisher
Jul 28, 2025

Immunocore stock price target raised to $36 from $33 at Mizuho - Investing.com

Jul 28, 2025
pulisher
Jul 27, 2025

Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $58.89 - Defense World

Jul 27, 2025
pulisher
Jul 24, 2025

Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

The IMCR Stock Puzzle: Unraveling Immunocore Holdings plc ADR’s Fluctuating Performance - investchronicle.com

Jul 24, 2025
pulisher
Jul 24, 2025

Can Mizuho Financial Group, Inc. ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 24, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Reduces Stock Holdings in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) - Defense World

Jul 13, 2025
pulisher
Jul 10, 2025

Immunocore Holdings ADR Earns IBD Rating Upgrade - Investor's Business Daily

Jul 10, 2025
pulisher
Jul 08, 2025

MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - sharewise.com

Jul 08, 2025
pulisher
Jul 08, 2025

COGT Stock Soars on Phase III Systemic Mastocytosis Study Success - sharewise.com

Jul 08, 2025
pulisher
Jul 02, 2025

5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment - Yahoo Finance

Jul 02, 2025
pulisher
Jul 01, 2025

Biogen Begins Phase III Felzartamab Study for Third Kidney Disease - Yahoo Finance

Jul 01, 2025
pulisher
Jun 25, 2025

KRYS Up 4% on Initiating Dosing in Rare Eye Disease Phase III Study - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN

Jun 24, 2025
pulisher
Jun 24, 2025

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer - Yahoo Finance

Jun 24, 2025
pulisher
Jun 23, 2025

FDA Extends INCY's Application for Opzelura Label Expansion - Yahoo Finance

Jun 23, 2025
pulisher
Jun 20, 2025

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech - Yahoo Finance

Jun 20, 2025
pulisher
Jun 17, 2025

AbbVie's Venclexta Misses Goal in Myelodysplastic Syndromes Study - Yahoo Finance

Jun 17, 2025
pulisher
Jun 14, 2025

Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges By Investing.com - Investing.com South Africa

Jun 14, 2025
pulisher
Jun 14, 2025

Immunocore’s SWOT analysis: stock outlook amid pipeline progress, market challenges - Investing.com India

Jun 14, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for Immunocore FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

GAMMA Investing LLC Boosts Stock Position in Immunocore Holdings plc (NASDAQ:IMCR) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India

Jun 05, 2025
pulisher
Jun 03, 2025

TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise

Jun 02, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com

May 27, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India

May 27, 2025
pulisher
May 26, 2025

Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com India

May 26, 2025
pulisher
May 24, 2025

Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN

May 24, 2025
pulisher
May 09, 2025

Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

New Strong Buy Stocks for May 8th - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates - Investing.com

May 07, 2025

Immunocore Holdings Plc Adr Azioni (IMCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):